Pfizer Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7170811035
USD
27.16
0.35 (1.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
17,557.00
16,654.00
14,653.00
13,715.00
17,763.00
17,702.00
13,283.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17,557.00
16,654.00
14,653.00
13,715.00
17,763.00
17,702.00
13,283.00
Raw Material Cost
6,541.00
5,471.00
5,233.00
3,888.00
4,795.00
6,931.00
5,040.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
711.00
652.00
654.00
654.00
739.00
783.00
778.00
Selling and Distribution Expenses
4,094.00
3,161.00
3,402.00
3,024.00
4,226.00
3,238.00
3,688.00
Other Expenses
242.20
184.00
178.90
152.50
227.80
178.20
189.80
Total Expenditure (Excl Depreciation)
13,768.00
11,124.00
11,078.00
9,091.00
12,038.00
12,734.00
11,404.00
Operating Profit (PBDIT) excl Other Income
3789
5530
3575
4624
5725
4968
1879
Other Income
838.00
573.00
309.00
152.00
1,595.00
545.00
91.00
Operating Profit (PBDIT)
6,314.00
7,765.00
5,509.00
6,394.00
9,111.00
7,268.00
3,701.00
Interest
711.00
652.00
654.00
654.00
739.00
783.00
778.00
Exceptional Items
-5,558.00
-2,117.00
-186.00
-1,338.00
-3,968.00
-15.00
-1,296.00
Gross Profit (PBDT)
11,016.00
11,183.00
9,420.00
9,827.00
12,968.00
10,771.00
8,243.00
Depreciation
1,687.00
1,662.00
1,625.00
1,618.00
1,791.00
1,755.00
1,731.00
Profit Before Tax
-1,642.00
3,334.00
3,044.00
2,784.00
-10.00
4,715.00
-103.00
Tax
-2.00
-216.00
141.00
-189.00
-421.00
234.00
-134.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1,648.00
3,541.00
2,885.00
2,967.00
403.00
4,473.00
24.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1,648.00
3,541.00
2,885.00
2,967.00
403.00
4,473.00
24.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
8.00
9.00
18.00
6.00
8.00
8.00
7.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1,640.00
3,550.00
2,903.00
2,973.00
411.00
4,481.00
31.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Reserves
86,476.00
92,801.00
88,695.00
90,338.00
88,203.00
92,286.00
87,700.00
Earnings per share (EPS)
-0.29
0.62
0.51
0.52
0.07
0.78
0.0
Diluted Earnings per share
-0.29
0.62
0.51
0.52
0.07
0.78
0.0
Operating Profit Margin (Excl OI)
21.58%
33.21%
24.4%
33.71%
32.23%
28.06%
14.15%
Gross Profit Margin
0.26%
30.0%
31.86%
32.1%
10.03%
36.55%
12.26%
PAT Margin
-9.39%
21.26%
19.69%
21.63%
2.27%
25.27%
0.18%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.42% vs 13.66% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -146.20% vs 22.29% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -23.86% vs 38.31% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 9.05% vs -0.31% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Pfizer Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
17,557.00
16,324.00
1,233.00
7.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
17,557.00
16,324.00
1,233.00
7.55%
Raw Material Cost
6,541.00
4,817.00
1,724.00
35.79%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
711.00
411.00
300.00
72.99%
Selling and Distribution Expenses
4,094.00
2,848.00
1,246.00
43.75%
Other Expenses
242.20
208.80
33.40
16.00%
Total Expenditure (Excl Depreciation)
13,768.00
10,164.00
3,604.00
35.46%
Operating Profit (PBDIT) excl Other Income
3,789.00
6,160.00
-2,371.00
-38.49%
Other Income
838.00
238.00
600.00
252.10%
Operating Profit (PBDIT)
6,314.00
8,864.00
-2,550.00
-28.77%
Interest
711.00
411.00
300.00
72.99%
Exceptional Items
-5,558.00
-2,567.00
-2,991.00
-116.52%
Gross Profit (PBDT)
11,016.00
11,507.00
-491.00
-4.27%
Depreciation
1,687.00
2,466.00
-779.00
-31.59%
Profit Before Tax
-1,642.00
3,420.00
-5,062.00
-148.01%
Tax
-2.00
458.00
-460.00
-100.44%
Provisions and contingencies
0
0
0.00
Profit After Tax
-1,648.00
2,963.00
-4,611.00
-155.62%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1,648.00
2,963.00
-4,611.00
-155.62%
Share in Profit of Associates
0
0
0.00
Minority Interest
8.00
-1.00
9.00
900.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1,640.00
2,962.00
-4,602.00
-155.37%
Equity Capital
0
0
0.00
Face Value
0.05
0.50
0.00
Reserves
86,476.00
52,606.00
33,870.00
64.38%
Earnings per share (EPS)
-0.29
1.19
-1.48
-124.37%
Diluted Earnings per share
-0.29
1.19
-1.48
-124.37%
Operating Profit Margin (Excl OI)
21.58%
37.74%
0.00
-16.16%
Gross Profit Margin
0.26%
36.06%
0.00
-35.80%
PAT Margin
-9.39%
18.15%
0.00
-27.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,755.70 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 5.42% vs 13.66% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -1.16% vs 21.91% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -164.00 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -146.20% vs 22.29% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -499.03% vs 112.32% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 547.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -23.86% vs 38.31% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -27.14% vs 1,746.68% in Dec 2024

Quarterly - Interest
Interest 71.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 9.05% vs -0.31% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -3.79% vs 7.26% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.58%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024